CN217772643U

CN217772643U - Cold plaster for botulinum toxin injection anesthesia

Info

Publication number: CN217772643U
Application number: CN202220244686.9U
Authority: CN
Inventors: 纪丽娜; 刘天一
Original assignee: Huadong Hospital
Current assignee: Huadong Hospital
Priority date: 2022-01-29
Filing date: 2022-01-29
Publication date: 2022-11-11
Anticipated expiration: 2032-01-29

Abstract

The application relates to the technical field of medical equipment, a botulinum toxin injection anesthesia cold application plaster is provided, including laminating the setting in proper order: a plaster layer of the anesthetic face, a water-absorbing auxiliary material layer and a cold application layer; the anesthetic mask layer is used for paralysis the part needing to be injected; the water absorption auxiliary material layer is used for absorbing the exudation of the skin after injection; the cold application layer is used for cold application hemostasis. The technical scheme of this application adopts a botulinum toxin injection anesthesia cold compress patch, can realize the cover of most steps in the whole botulinum toxin injection operation, has reduced the quantity of the required equipment in the art, has also alleviateed doctor's operation complexity, has improved the continuity of operation. The medical treatment system can shorten the treatment time of doctors on the whole and improve the comfort of patients.

Description

Botulinum toxin injection anesthesia cold plaster

Technical Field

The application relates to the technical field of medical instruments, in particular to a botulinum toxin injection anesthesia cold application patch.

Background

Botulinum Toxin (BTX, botulin Toxin), also known as Botulinum Toxin or Botulinum Toxin, is a neurotoxin protein produced by Botulinum during reproduction. Botulinum toxin is a 150kD polypeptide consisting of a 100kD heavy (H) chain linked to a 50kD light (L) chain by a disulfide bond. Based on their toxicity and antigenicity, they are classified into A, B, ca, cb, D, E, F and G8 types. Botulinum toxin is one of the most toxic natural substances and is also one of the most toxic proteins in the world. Purified crystalline botulinum toxin 1mg kills 2 million mice, with a median lethal dose to humans of 40IU/Kg. But has stable property and is easy to produce, purify and refine. Therefore, it was first used in experimental research and clinical practice.

Since botulinum toxin is a nerve anesthetic and can paralyze muscles temporarily, the medical community has used botulinum toxin as a therapeutic drug for clinical treatment of strabismus from 1 st 1979, and the botulinum toxin has been used for over 30 years. In 1986, an ophthalmic professor in Canada found that the medicine for paralyzing the muscle nerve can block the information transmission between the motor nerve and the muscle, and can eliminate wrinkles or avoid the generation of wrinkles in a period of time, thereby achieving the effect of beautifying. Soon, cosmetic surgery with botulinum toxin injection has been ongoing and rapidly spread to the world.

With the continuous progress and development of society, the application of the botulinum toxin injection surgery is also increasingly wide. The injection process of the prior art botulinum toxin injection operation is complicated and draggy, doctors cannot operate continuously, and the treatment time of patients is long.

SUMMERY OF THE UTILITY MODEL

In order to solve or at least partially solve the technical problem, the application provides a botulinum toxin injection anesthesia cold patch, which comprises: laminating in proper order and setting up: a gunpowder surface film layer, a water absorption auxiliary material layer and a cold application layer; the anaesthetic mask layer is used for paralysis of the part needing injection; the water-absorbing auxiliary material layer is used for absorbing exudates of the skin after injection; the cold application layer is used for cold application hemostasis.

Optionally, the method further comprises: and the film layer is attached to the anesthetic face adhesive layer and used for keeping the aseptic state of the anesthetic face adhesive layer.

Optionally, the surface of the film layer facing the anesthetic face adhesive film layer is provided with protruding points in an array mode, and the surface back to the anesthetic face adhesive film layer is a smooth surface.

Optionally, the composition of the anesthetic mask layer comprises 1% +/-0.5% effective content of chlorhexidine acetate in W/W and tricaine hydrochloride, and the thickness of the anesthetic mask layer is between 1mm and 2 mm; the water absorption auxiliary material layer comprises a cotton gauze layer and two non-woven fabric layers which sandwich the cotton gauze layer; the cold application layer comprises a heat-storage gel wrapped by thermoplastic polyurethane elastomer rubber.

Optionally, the method further comprises: and the water-proof film layer is attached to the cold application layer and is made of non-woven fabrics.

Optionally, the layers of the botulinum toxin injection anesthetic cold patch are attached together by suture stitching.

Optionally, the suture thread is sewed along the edge of the botulinum toxin injection anesthetic cold patch, and the suture thread is sewed at least in the three-side direction of the botulinum toxin injection anesthetic cold patch.

Optionally, two mesh holes penetrating through each layer of structure are formed in the botulinum toxin injection anesthetic cold compress patch, and when the botulinum toxin injection anesthetic cold compress patch is attached to the face of a human body, the positions of the mesh holes correspond to the eyes.

Optionally, the opposing sides of the botulinum toxin injection anesthetic cold patch are curved toward the same side.

Optionally, the botulinum toxin injection anesthetic cold application is further provided with a plurality of injection holes penetrating through each layer structure.

Optionally, when the botulinum toxin injection anesthetic cold compress is attached to a human face, the injection hole is positioned to correspond to at least one of: frontalis, glabellar internus, frown, orbicularis oculi, nasal septum levator, and dorsalis nasalis.

The technical scheme of this application adopts a botulinum toxin injection anesthesia cold compress patch, can realize the cover of most steps in the whole botulinum toxin injection operation, has reduced the quantity of required equipment in the art, has also alleviateed doctor's operation complexity, has improved the continuity of operation. The medical treatment system can shorten the treatment time of doctors on the whole and improve the comfort of patients.

Drawings

In order to more clearly describe the embodiments of the present application, a brief description will be given below of the relevant drawings. It is to be understood that the drawings in the following description are only intended to illustrate some embodiments of the present application, and that a person skilled in the art may also derive from these drawings many other technical features and connections etc. not mentioned herein.

Fig. 1 is a schematic cross-sectional structure diagram of a botulinum toxin injection anesthesia cold patch provided by the present application.

Fig. 2 is a front schematic view of a botulinum toxin injection anesthesia cold patch provided by the present application.

FIG. 3 is a schematic front view of another botulinum toxin injection anesthetic cold patch provided herein.

Fig. 4 is a schematic diagram showing the corresponding positions of injection holes of a botulinum toxin injection anesthesia cold patch provided by the present application.

The reference numerals and names in the figures are as follows:

1. a thin film layer; 2. a plaster layer is pasted on the surface of the anesthetic; 3. a water-absorbing auxiliary material layer; 4. a cold application layer; 5. a water barrier film layer; 6. a suture thread; 7. mesh holes; 8. an injection hole; 9. and an air outlet.

Detailed Description

The technical solutions in the embodiments of the present application will be described in detail below with reference to the drawings in the embodiments of the present application.

The inventor of the application finds that the prior art aims at the treatment of facial wrinkle removal by using botulinum toxin, and needs to be divided into a plurality of steps such as anesthesia, injection, cleaning, cold compress hemostasis and the like, each step needs to independently use different types of instruments and devices, so that a doctor cannot continuously operate the operation, and the treatment time is long.

In view of the above, in an embodiment of the present application, a botulinum toxin injection anesthesia cold patch is provided.

Implementation mode one

The present application provides a botulinum toxin injection anesthesia cold patch, as shown in figures 1 and 2, comprising: laminating in proper order sets up: a plaster layer of the anesthetic face, a water-absorbing auxiliary material layer and a cold application layer; the anaesthetic mask layer is used for paralysis of the part needing injection; the water-absorbing auxiliary material layer is used for absorbing exudates of the skin after injection; the cold application layer is used for cold application hemostasis.

Wherein, the thickness of the anaesthetic mask pasting layer is between 1mm and 2mm, in particular 1.5mm. The thickness of the water-absorbing auxiliary material layer is about 5mm to 8mm. The thickness of the cold application layer is about 1.5-2.2mm, and the total thickness is controlled within 18 mm.

The botulinum toxin injection anesthesia cold patch of the present application is suitable for facial botulinum toxin wrinkle removal treatment, and thus may have an overall length of about 18cm and a width of about 8cm to fit the size of a human face. Alternatively, as shown in fig. 2, the botulinum toxin injection anesthetic cold patch may be provided with two mesh holes penetrating through each layer structure, the mesh holes corresponding in position to the eyes when the botulinum toxin injection anesthetic cold patch is attached to the face of a human body. In addition, the botulinum toxin injection anesthesia cold patch of the present application may cover only half of the patient's face as shown in fig. 2, or may cover the entire face of the patient as shown in fig. 3. At the moment, an air outlet corresponding to the nose can be arranged on the botulinum toxin injection anesthesia cold compress patch.

For better attachment to the patient's face, the opposing sides of the botulinum toxin injection anaesthetic cold patch may optionally be curved towards the same side, forming a meniscus shaped cross-section that will provide a better fit to the human face.

Optionally, the botulinum toxin injection anesthesia cold patch of the present application may further comprise: and the film layer is attached to the anesthetic face adhesive layer and used for keeping the aseptic state of the anesthetic face adhesive layer. The film layer can be made of high molecular materials, and particularly can be made of food-grade plastics. The arranged film layer can well prevent pollution and keep the sterile state of the anaesthetic mask layer. Optionally, the surface of the film layer facing the anesthetic face adhesive film layer can be provided with protruding points in an array manner, and the surface facing away from the anesthetic face adhesive film layer is a smooth surface. The protruding points can prevent the film layer from being excessively adhered to the anesthetic in the anesthetic face pasting layer, and the film layer is convenient to uncover in use.

Optionally, the composition of the anaesthetic mask layer comprises 1% +/-0.5% effective content, W/W chlorhexidine acetate, tricaine hydrochloride and the like, and the thickness of the anaesthetic mask layer is between 1mm and 2 mm; the water absorption auxiliary material layer comprises a cotton gauze layer and two non-woven fabric layers which sandwich the cotton gauze layer; the cold application layer comprises a heat-storage gel wrapped by thermoplastic polyurethane elastomer rubber. The components of the anesthetic face mask layer have an antibacterial effect and can inhibit staphylococcus aureus, escherichia coli, candida albicans and the like, and the anesthetics are uniformly covered on the plastic film, so that the anesthetic effect and the antibacterial effect can be achieved.

Optionally, the water-absorbing auxiliary material layer can be of a three-layer structure, and the middle layer can be of a cotton gauze with a loose structure and has water-absorbing performance. The inner layer and the outer layer 2 are cotton non-woven fabrics, and the three layers are closely connected, so that the cotton yarn cloth with loose middle has a protection effect.

Optionally, the cold application layer can be TPU + cold storage gel with the thickness of 1.5-2.2mm, so that the cold storage layer has a good cold storage effect on the premise of small thickness. Before use, the product is recommended to be put into a refrigerating chamber (a fresh-keeping chamber) of a refrigerator for 30-60 min for use, and is usually put in a cool and dry place, so that the product is not suitable for being stored in the refrigerator for a long time. The cold compress layer can replace an additionally arranged fussy ice compress flow, and can play a role in assisting anesthesia.

Optionally, the toxin injection anesthetic cold patch may further comprise: and the water-proof film layer is attached to the cold application layer and is made of non-woven fabric. The waterproof film layer can be a double-layer cotton non-woven fabric with a dense structure, the double layers are tightly connected, and the waterproof film layer can have water absorption performance while resisting water.

It is worth mentioning that the layers of the botulinum toxin injection anesthesia cold patch can be connected in various ways, such as by using an adhesive patch or a magnetic patch. Optionally, the layers of the botulinum toxin injection anaesthetic cold patch may be attached by suture stitching. Further optionally, the suture thread is sewn along an edge of the botulinum toxin injection anesthetic cold patch, and the suture thread is sewn in at least a three-sided direction of the botulinum toxin injection anesthetic cold patch. The suture line has low cost and is easy to tear. In addition, when the film layer is arranged, the film layer and the anesthetic face film layer can be naturally bonded, so that the film layer and the anesthetic face film layer are not required to be sewn through a suture line, and the convenience is improved.

The application also provides a use method of the botulinum toxin injection anesthesia cold patch, which comprises the following steps:

1. before use, the botulinum toxin injection anesthesia cold patch can be placed in a refrigerator cold storage chamber (fresh-keeping chamber) for 30min-60min for use. Of course, it is usually recommended to be placed in a cool and dry place, and it is not suitable to be stored in a refrigerator for a long time.

2. In operation, the film layer is torn to expose the anesthetic face film layer, and the anesthetic face film layer is directly pasted on the upper face of a patient and exposes the eye position of the patient through the eye hole. The anesthetic will be applied directly to the patient's face at the site to be injected. With the aid of the cold application layer, the anesthesia efficiency of the anesthetic can be improved.

3. Wait for 30 minutes to 1 hour, and then observe the condition of the patient. Generally, at this point the patient will self-describe feeling that the area has been numbed, and may then proceed with injections of botulinum toxin.

4. Taking off the botulinum toxin injection anesthesia cold patch, and placing aside for standby.

5. Injecting botulinum toxin to the corresponding area of the patient's face.

6. Tearing off the anesthetic mask layer to expose the water-absorbing auxiliary material layer, applying the water-absorbing auxiliary material layer on the face of the patient to absorb the exudate of the skin after injection, and cold application layer can help pressure hemostasis and cold application sedation. The water-proof film layer can prevent the influence on the cold application of the botulinum toxin injection anesthesia due to the generation of a large amount of condensed water caused by the over-low temperature of the cold application layer.

The technical scheme of this application adopts a botulinum toxin injection anesthesia cold compress patch, can realize the cover of most steps in the whole botulinum toxin injection operation, has reduced the quantity of the required equipment in the art, has also alleviateed doctor's operation complexity, has improved the continuity of operation. The medical treatment system can shorten the treatment time of doctors on the whole and improve the comfort of patients.

Second embodiment

A second embodiment of the present application provides a botulinum toxin injection anesthesia cold patch. The second embodiment is a further modification of the first embodiment. The improvement is that in the second embodiment of the application, the botulinum toxin injection anesthetic cold application is further provided with a plurality of injection holes penetrating through each layer structure.

Specifically, optionally, referring to fig. 4, when the botulinum toxin injection anesthetic cold compress patch is attached to the face of a human body, the injection hole is located corresponding to at least one of the following parts: frontal muscle, glabellar muscles, frown muscles, orbicularis oculi muscles, levator nasalis, dorsum nasalis, etc.

Fig. 4 is a convenient illustration of the position of the injection hole corresponding to the facial region, and in actual use, the size and position of the injection hole can be adjusted as required, and the size is generally smaller than that shown in the figure. When the injection hole is arranged, the injection can be carried out on the face of a human body without undoing the botulinum toxin injection anesthesia cold application. The injection holes may also significantly improve the accuracy of the injection site.

When the injection hole is arranged, the application also provides a use method of the botulinum toxin injection anesthesia cold patch, which comprises the following steps:

1. before use, the botulinum toxin injection anesthesia cold patch can be placed in a refrigerator cold storage chamber (fresh-keeping chamber) for 30min-60min for use.

2. In operation, the film layer is torn to expose the anesthetic face film layer, and the anesthetic face film layer is directly pasted on the upper face of a patient and exposes the eye position of the patient through the eye hole. The anesthetic will act directly on the patient's face at the site to be injected.

3. Wait for 30 minutes to 1 hour and then observe the condition of the patient. Generally, at this point the patient will self-describe that the area has been numbed and may then proceed with an injection of botulinum toxin. With the aid of the cold application layer, the anesthetic efficiency of the anesthetic can be improved.

4. Injecting botulinum toxin to the corresponding portion of the patient's face through the injection hole.

5. Tearing off the anaesthetic mask layer to expose the water-absorbing auxiliary material layer, applying the water-absorbing auxiliary material layer to the face of a patient so as to absorb exudates of skin after injection, and applying the cold dressing layer to assist pressurization hemostasis and cold dressing sedation. The water-proof film layer can prevent the influence on the cold application of the botulinum toxin injection anesthesia due to the generation of a large amount of condensed water caused by the over-low temperature of the cold application layer.

It will be evident to those skilled in the art that the present application is not limited to the details of the foregoing illustrative embodiments, and that the present application may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the application being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. Any reference sign in a claim should not be construed as limiting the claim concerned.

Claims

1. A botulinum toxin injection anesthesia cold patch, comprising:

laminating in proper order sets up: a gunpowder surface film layer, a water absorption auxiliary material layer and a cold application layer;

the anesthetic mask layer is used for paralysis the part needing injection;

the water absorption auxiliary material layer is used for absorbing the exudates of the skin after injection;

the cold application layer is used for cold application hemostasis.

2. The botulinum toxin injection anesthetic cold patch according to claim 1, further comprising: and the film layer is attached to the anesthetic face pasting layer and used for keeping the sterile state of the anesthetic face pasting layer.

3. The botulinum toxin injection anesthetic cold patch according to claim 2, wherein the film layer is provided with raised points in an array on a side facing the anesthetic face patch layer, and a side facing away from the anesthetic face patch layer is smooth.

4. The botulinum toxin injection anesthetic cold patch according to claim 1, characterized in that the anesthetic mask layer has a thickness between 1mm and 2 mm;

the water absorption auxiliary material layer comprises a cotton gauze layer and two non-woven fabric layers wrapping the cotton gauze layer;

the cold application layer comprises cold storage gel wrapped by thermoplastic polyurethane elastomer rubber.

5. The botulinum toxin injection anesthetic cold patch according to claim 1, further comprising: and the water-proof film layer is attached to the cold application layer and is made of non-woven fabrics.

6. The botulinum toxin injection anesthetic cold patch according to claim 1, characterized in that the layers of the botulinum toxin injection anesthetic cold patch are connected by suture.

7. The botulinum toxin injection anesthetic cold patch according to claim 6, characterized in that said suture thread is sewn along an edge of said botulinum toxin injection anesthetic cold patch, and said suture thread is sewn at least in a three-sided direction of said botulinum toxin injection anesthetic cold patch.

8. The botulinum toxin injection anesthetic cold patch according to claim 1, wherein two mesh holes penetrating through each layer structure are formed on the botulinum toxin injection anesthetic cold patch, when the botulinum toxin injection anesthetic cold patch is attached to a face of a human body, the mesh holes are positioned corresponding to eyes, and two opposite sides of the botulinum toxin injection anesthetic cold patch are bent towards the same side.

9. The botulinum toxin injection anesthetic cold patch according to any one of claims 1 to 8, characterized in that a plurality of injection holes penetrating the respective layer structures are further provided on said botulinum toxin injection anesthetic cold patch.

10. The botulinum toxin injection anesthetic cold patch according to claim 9, wherein the injection hole is positioned to correspond to at least one of the following parts when the botulinum toxin injection anesthetic cold patch is attached to a human face:

frontalis, glabellar internus, frown, orbicularis oculi, nasal septum levator, dorsum nasalis.